Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ak0529 (8 trials)
ak3280 (2 trials)
Infections (Phase 3)
Respiratory Syncytial Virus Infections (Phase 3)
Virus Diseases (Phase 3)
Trials (10 total)
Trial APIs (2 total)